These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24670474)

  • 1. Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.
    Herrera B; Dooley S; Breitkopf-Heinlein K
    Int J Mol Sci; 2014 Mar; 15(4):5199-220. PubMed ID: 24670474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.
    Herrera B; García-Álvaro M; Cruz S; Walsh P; Fernández M; Roncero C; Fabregat I; Sánchez A; Inman GJ
    PLoS One; 2013; 8(7):e69535. PubMed ID: 23936038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.
    Maegdefrau U; Bosserhoff AK
    Exp Mol Pathol; 2012 Feb; 92(1):74-81. PubMed ID: 22024355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cells.
    Li Q; Gu X; Weng H; Ghafoory S; Liu Y; Feng T; Dzieran J; Li L; Ilkavets I; Kruithof-de Julio M; Munker S; Marx A; Piiper A; Augusto Alonso E; Gretz N; Gao C; Wölfl S; Dooley S; Breitkopf-Heinlein K
    Cancer Sci; 2013 Mar; 104(3):398-408. PubMed ID: 23281849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling.
    Qiu H; Yang B; Pei ZC; Zhang Z; Ding K
    J Biol Chem; 2010 Oct; 285(42):32638-46. PubMed ID: 20679340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
    Zulehner G; Mikula M; Schneller D; van Zijl F; Huber H; Sieghart W; Grasl-Kraupp B; Waldhör T; Peck-Radosavljevic M; Beug H; Mikulits W
    Am J Pathol; 2010 Jan; 176(1):472-81. PubMed ID: 20008139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling.
    Frohlich J; Mazza T; Sobolewski C; Foti M; Vinciguerra M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jun; 1866(6):158920. PubMed ID: 33684566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
    Matsuzaki K
    Cell Tissue Res; 2012 Jan; 347(1):225-43. PubMed ID: 21626291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.
    Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
    Tumour Biol; 2014 Jun; 35(6):5189-98. PubMed ID: 24573607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between TGF-β/SMAD and BMP/SMAD signaling pathways in the epithelial mesenchymal transition of A549 cells induced by silica.
    Yu Y; Lin Y; Yang G; Tian L
    Toxicol Mech Methods; 2018 May; 28(4):286-292. PubMed ID: 29161937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.
    Caja L; Bertran E; Campbell J; Fausto N; Fabregat I
    J Cell Physiol; 2011 May; 226(5):1214-23. PubMed ID: 20945437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
    Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
    Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.
    Chang HM; Qiao J; Leung PC
    Hum Reprod Update; 2016 Dec; 23(1):1-18. PubMed ID: 27797914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMPS and liver: more questions than answers.
    Herrera B; Sánchez A; Fabregat I
    Curr Pharm Des; 2012; 18(27):4114-25. PubMed ID: 22630083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospect of bone morphogenetic protein 13 in liver diseases.
    Li Y; Shen H; Burczynski FJ; Gong Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):1-5. PubMed ID: 22349385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
    Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L
    Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis.
    Inai K; Norris RA; Hoffman S; Markwald RR; Sugi Y
    Dev Biol; 2008 Mar; 315(2):383-96. PubMed ID: 18261719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.